Phase 1 Gastroenteropancreatic Neuroendocrine Tumor Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Solid TumorNeuroendocrine TumorsGep Net+6 more

RayzeBio, Inc.104 enrolled9 locationsNCT07165132

Recruiting

Phase 1Phase 2

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

ParagangliomaPheochromocytomaMeningioma+4 more

Perspective Therapeutics300 enrolled19 locationsNCT05636618

Recruiting

Phase 1

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Gastroenteropancreatic Neuroendocrine Tumor

Stanford University10 enrolled1 locationNCT04609592